Abstract:Objectives: To evaluate the associations between bone mineral density (BMD) and metabolism syndromes (MS) among Chinese adults Methods: 46,285 Chinese adults were recruited in a prospective urban and rural epidemiological study in China (PURE-China). During the 6-to-9-year follow-up at 2013–2017, 3,457 participants from 7 centers (Beijing, Jiangsu, Shanxi, Shaanxi, Liaoning, Jiangxi, and Sichuan) underwent a low dose abdominal CT scan with QCT capacity for BMD measurement of L1–3. MS is diagnosed if at least three of the following criteria are met: 1) waist circumference (WC) > 101 cm in males and > 89 cm in female; 2) triglycerid≥1.70mmol/L or had corresponding treatment; 3) high density lipoprotein-cholesterol < 1.0 mmol/L for males and < 1.3 mmol/L for females or had corresponding treatment; 4) systolic/diastolic blood pressure≥130/85mmHg or self-reported hypertension or had blood pressure medication; 5) fasting glucose≥5.6 mmol/L or self-reported diabetes or had anti-diabetic medication. Results: 3341 participants with complete data available were included for analysis. 54.7% from urban areas, more females were enrolled (62.7%) and mean age was 61.3 ± 9.0 years old (ranged from 40 to 81) when QCT were conducted. The mean of spine BMD was 107.6 ± 37.8 mg/cm3, and 39.8% was diagnozed as osteopenia (BMD ranged at 80–120 mg/cm3) and 24.7% as osteoporosis (BMD < 80 mg/cm3). The positive association between osteopenia or osteoporosis risk and MS was observed only among females (Odds ratio [OR], 1.67; 95% confidence interval [CI], 1.34–2.10) and older adults (OR, 1.32; 95% CI, 1.01–1.71), but not males and middle-aged adults. Conclusion: Conclusively, the result of regression analysis between MS and bone density reducation risk may be different in men and women, as well as older and middle-aged adults.

THE POTENTIAL ASSOCIATION OF SPINE BONE MINERAL DENSITY WITH METABOLISM SYNDROMES